Hologic, Inc., a leading global medical technology company headquartered in the United States, has been at the forefront of women's health since its founding in 1982. With a strong presence in North America, Europe, and Asia, Hologic focuses on innovative solutions in the fields of diagnostics, medical imaging, and surgical products. Renowned for its advanced technologies, Hologic's core offerings include breast health, gynaecological health, and skeletal health solutions, which are distinguished by their precision and efficacy. The company has achieved significant milestones, including pioneering developments in 3D mammography and molecular diagnostics, solidifying its position as a market leader. Hologic's commitment to improving patient outcomes and enhancing healthcare efficiency has earned it numerous accolades, making it a trusted name in the medical technology industry.
How does Hologic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hologic's score of 76 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Hologic, Inc. reported total greenhouse gas emissions of approximately 492,435,000 kg CO2e. This includes 7,050,000 kg CO2e from Scope 1 emissions, 14,705,000 kg CO2e from Scope 2 emissions, and a significant 350,665,000 kg CO2e from Scope 3 emissions. The company has set ambitious targets to reduce its carbon footprint, aiming for a 30% reduction in Scope 1 and 2 emissions by 2030, based on a 2020 baseline. Furthermore, Hologic is committed to achieving a 50% reduction in these emissions by 2030 and a 90% reduction by 2050. Hologic's climate strategy also includes a commitment to reach net-zero emissions across all scopes by 2050. This includes a 90% reduction in absolute Scope 3 emissions within the same timeframe. The company has also pledged to increase its sourcing of renewable electricity from 9% in FY2020 to 100% by FY2030. The emissions data and reduction targets are not cascaded from any parent organization, indicating that Hologic is independently managing its climate commitments. These initiatives align with industry standards and reflect Hologic's dedication to sustainability within the healthcare equipment and supplies sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | - | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
Hologic's Scope 3 emissions, which decreased by 12% last year and decreased by approximately 33% since 2020, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 81% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hologic has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Hologic's sustainability data and climate commitments